Physician's First Watch Archive

Medical news from NEJM Journal Watch

March 27, 2017

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Avoiding all tree nuts might not be necessary in people who have a single tree nut allergy, suggests a study in Annals of Allergy, Asthma and Immunology.

Researchers analyzed data from over 150 tree nut oral food …

By the Editors

In case you missed it, House Republicans decided not to put …

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Duloxetine, venlafaxine, pregabalin, oxcarbazepine, tricyclic antidepressants, atypical opioids (e.g., tapentadol), and botulinum toxin are all more effective than placebo in reducing …

March 25, 2017

March 24, 2017

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Many children and adolescents with diabetes aren't being screened for diabetic retinopathy soon after their diagnosis, according to a retrospective study in …

By Cara Adler

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Starting in 2013, the number of U.S. tuberculosis diagnoses among foreign-born people was higher in those who had arrived many years before diagnosis than …

March 23, 2017

By Amy Orciari Herman

Edited by Susan Sadoughi, MD

Moderate alcohol consumption seems associated with lower cardiovascular risks, but the relationship is highly nuanced, a study in The BMJ finds.

Researchers linked U.K. primary care, hospital, and mortality records to examine associations between …

By Joe Elia

Edited by Susan Sadoughi, MD

A study of the Affordable Care Act's effects in California, New York, Florida, and Texas seems to show that Medicaid expansion was associated with better coverage and …

By the Editors

Here's today's offering from NEJM Group:

NEJM Audio Interview: Depression and Suicidality in Medicine: Dr. Stuart Slavin discusses depression and suicide among physicians …

By Kristin J. Kelley

Edited by Susan Sadoughi, MD

The FDA has approved safinamide (marketed as Xadago) for treating increased symptoms of Parkinson disease. The drug is indicated as add-on therapy for patients in whom …

By the Editors

Pregabalin (Lyrica) doesn't seem to improve sciatica pain, according to a study in the New England Journal of …

March 22, 2017

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Two new cohort studies in JAMA shed light on the adverse events associated with various treatments for localized prostate cancer.

In the first study, researchers compared patient-reported outcomes at 3 …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Increases in televised direct-to-consumer testosterone ads were associated with increases in serum testosterone testing and treatment initiation over a 4-year period, a JAMA …

By the Editors

Here are today's selected readings from NEJM Group:

NEJM Clinical Practice Center: Perspective: Many heroin users abstain from use while taking buprenorphine, but the daily decision to take …

By Joe Elia

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Breast implant-associated anaplastic large cell lymphomas — a rare condition — occur more …

By the Editors

Prenatal docosahexaenoic acid (DHA) supplementation does not lead to improved IQ in school-aged children, according to findings reported …

March 21, 2017

By Amy Orciari Herman

Edited by Jaye Elizabeth Hefner, MD

A single glucocorticoid injection offers short-term relief of chronic back pain associated with discopathy, according to a study in the Annals of Internal Medicine. But the benefits are …

Pages